找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Biotechnology in India - Reworking A Strategy; George John,Amulya K. Panda Book 2024 The Editor(s) (if applicable) and The Author(s), unde

[復(fù)制鏈接]
樓主: hypothyroidism
11#
發(fā)表于 2025-3-23 12:59:47 | 只看該作者
Marine Biotechnology in India: Status and Unfolding Opportunitiese centrepiece where different disciplines are converging to generate food and wealth..The phenomenal potential of the non-food sector of marine biotechnology unfolds through the promise of new drugs and bioactive compounds. Enzymes from various types of extremophilic marine organisms can lead to ind
12#
發(fā)表于 2025-3-23 15:31:12 | 只看該作者
Unveiling Fundamentals and Research Opportunities of mRNA Technologyse platforms, manufacturing intricacies, and inherent advantages. Initially conceptualized within the framework of the central dogma of molecular biology in the 1950s–1960s, mRNA serves as an intermediary for genetic information translation into functional proteins. This chapter delves into the vari
13#
發(fā)表于 2025-3-23 21:58:52 | 只看該作者
Vaccine Research and Development in India for COVID-19 and Influenzathe world’s largest vaccine manufacturers and has successfully vaccinated a large fraction of its population to protect against COVID-19 disease caused by the sarbecovirus, SARS-CoV-2. However, much of this was reliant on formulations developed elsewhere, and before vaccines could be widely deployed
14#
發(fā)表于 2025-3-24 02:05:24 | 只看該作者
Development of Genetically Engineered Vaccine and Post-Exposure Therapy Against Anthraxcal weapon, research and development of effective vaccines and post-exposure therapeutics has been crucial. Currently available anthrax vaccines such as Anthrax Vaccine Adsorbed (AVA) and Anthrax Vaccine Precipitate (AVP) are tightly regulated and not commercially available. FDA approved prophylacti
15#
發(fā)表于 2025-3-24 03:41:48 | 只看該作者
16#
發(fā)表于 2025-3-24 08:27:38 | 只看該作者
17#
發(fā)表于 2025-3-24 10:44:06 | 只看該作者
18#
發(fā)表于 2025-3-24 15:15:46 | 只看該作者
19#
發(fā)表于 2025-3-24 19:10:38 | 只看該作者
Catalysing and Accelerating a New Phase in Indian Biopharmactively through ‘reverse engineering’ skills. A similar success story lies behind biogenerics produced through the biotech route. These remarkable successes have laid a solid foundation for a cash-rich and confident pharmaceutical industry to successfully cater to the ever-growing need for affordabl
20#
發(fā)表于 2025-3-25 01:50:24 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 21:36
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
酉阳| 屯留县| 高密市| 鄂温| 饶平县| 商丘市| 闻喜县| 方城县| 灵武市| 大同县| 阿拉善右旗| 社会| 五寨县| 兰州市| 天台县| 桐柏县| 太和县| 平度市| 樟树市| 金寨县| 和田市| 监利县| 黄石市| 金溪县| 墨玉县| 舞阳县| 长春市| 伊吾县| 逊克县| 宜良县| 休宁县| 亚东县| 禹州市| 和硕县| 樟树市| 麻城市| 东阿县| 潼关县| 西吉县| 通化市| 徐汇区|